Psychedelic Medicine, volume 3, issue 1, pages 1-18

A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research

David B. Yaden ¹

Marianna Graziosi ^{1, 2}

Alexa M. Owen ³

Gabrielle Agin-Liebes ^{4, 5}

Scott M. Aaronson ^{6, 7}

Katja Ehrmann Allen ⁸

FREDERICK C. BARRETT ^{1, 9, 10}

Michael P. Bogenschutz ¹¹

Robin Carhart-Harris ⁵

Terence H. W. Ching ¹²

Mary P. Cosimano ¹³

Alicia Danforth ¹⁴

Alan K. Davis ^{1, 15}

Albert Garcia-Romeu ¹

R. R. Griffiths ¹

CHARLES S. GROB ¹⁴

Gerhard Gründer ^{16, 17}

Natalie Gukasyan ¹⁸

Keith G. Heinzerling ¹⁹

Peter S. Hendricks ²⁰

Friederike Holze ^{21, 22}

David M. Horton ²³

Matthew W. Johnson ^{24, 25}

Benjamin Kelmendi ¹²

Stephanie Knatz Peck ²⁶

Michael Koslowski ^{27, 28}

M Liechti ^{21, 22}

Lea J Mertens ^{16, 17}

Francisco A. Moreno ²⁹

Sandeep M. Nayak ¹

Christopher D Nicholas ²³

Katrin H Preller ³⁰

Nathalie M Rieser ³⁰

Stephen Ross ¹¹

Karina Sergi ¹⁹

Jordan Sloshower ¹²

Lukasz Smigielski ³¹

Dea Siggaard Stenbæk ^{32, 33}

Franz X. Vollenweider ³⁰

Brandon Weiss ¹

Max Wolff ^{27, 34}

Mary Elizabeth Yaden ¹

Show full list: 42 authors

Hide authors affiliations

Center for Psychedelic and Consciousness Research, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. |

Department of Clinical Psychology, Hofstra University, Hempstead, New York, USA. |

Smith College School for Social Work, Northampton, Massachusetts, USA. |

⁴

Department of Psychiatry, University of California, San Francisco, California, USA. |

⁵

Institute for Advanced Diagnostics and Therapeutics, Sheppard Pratt, Towson, Maryland, USA.

⁶

University of Maryland School of Medicine, Baltimore, Maryland, USA. |

⁷

University of Arizona, Tucson, Arizona, USA. |

⁸

Department of Psychological & Brain Sciences, Krieger School of Arts & Sciences, Johns Hopkins University, Baltimore, Maryland, USA. |

⁹

Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. |

¹⁰

Department of Psychiatry, NYU Langone Center for Psychedelic Medicine, NYU Grossman School of Medicine, New York, New York, USA. |

¹¹

Department of Neurology, University of California San Francisco, San Francisco, California, USA. |

¹²

Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut, USA. |

¹³

Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. |

¹⁴

The Lundquist Institute at the Harbor-UCLA Medical Center, Torrance, California, USA. |

¹⁵

Center for Psychedelic Drug Research and Education, College of Social Work, The Ohio State University, Columbus, Ohio, USA. |

¹⁶

Central Institute of Mental Health, Department of Molecular Neuroimaging, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.

¹⁷

German Center for Mental Health (DZPG), Partner Site Mannheim, Mannheim, Germany. |

¹⁸

New York State Psychiatric Institute, Columbia University Medical Center, New York, New York, USA. |

¹⁹

Treatment and Research In Psychedelics (TRIP) Center, Pacific Neuroscience Institute at Providence Saint John’s Health Center, Santa Monica, California, USA.

²⁰

Department of Psychiatry and Behavioral Neurobiology, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA. |

²¹

Clinical Pharmacology and Toxicology, Department of Biomedicine and Department of Clinical Research, University Hospital Basel and University of Basel, Basel, Switzerland. |

²²

Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland. |

²³

Department of Family Medicine and Community Health, University of Wisconsin, Madison, Wisconsin, USA. |

²⁴

Center of Excellence for Psilocybin Research and Treatment, Sheppard Pratt, Townson, Maryland, USA. |

²⁵

Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. |

²⁶

Department of Psychiatry, University of California San Diego, San Diego, California, USA. |

²⁷

Department of Psychiatry and Psychotherapy, Charité CCM—Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.

²⁸

Iméra Institute of Advanced Studies, Aix Marseille University, Marseille, France. |

²⁹

College of Medicine Tucson, University of Arizona, Tucson, Arizona, USA. |

³⁰

Department of Adult Psychiatry and Psychotherapy, Psychiatric University Clinic Zurich, University of Zurich, Zurich, Switzerland. |

³¹

Department of Child and Adolescent Psychiatry and Psychotherapy, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland. |

³²

Neurobiology Research Unit, Copenhagen University Hospital, Rigshospitalet, Denmark. |

³³

Department of Psychology, Copenhagen University Clinic for Psychedelic Research, University of Copenhagen, Copenhagen, Denmark. |

³⁴

MIND Foundation gGmbH, Berlin, Germany. |

Publication type: Journal Article

Publication date: 2025-03-01

Mary Ann Liebert

Journal: Psychedelic Medicine

SJR: —

CiteScore: —

Impact factor: —

ISSN: 28314425, 28314433

DOI: 10.1089/psymed.2024.0019

Copy DOI

Found

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.

Metrics

Cite this

GOST | RIS | BibTex | MLA

Found error?

Publisher

Mary Ann Liebert

Journal

Psychedelic Medicine

SJR

—

CiteScore

—

Impact factor

—

ISSN

28314425 (Print)

28314433 (Electronic)